← Evidence map

ArticleMolecular cancer therapeutics2020

EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.

Christen Dillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32451329